Literature DB >> 1892312

Idiopathic pulmonary fibrosis in asbestos-exposed workers.

E A Gaensler1, P J Jederlinic, A Churg.   

Abstract

Diffuse interstitial lung disease in asbestos-exposed workers is presumed to represent asbestosis. Among 176 asbestos-exposed persons for whom lung tissue was available, we found nine with clinical features consistent with asbestosis, but histologic sections failed to demonstrate asbestos bodies, the usual requirement for pathologic diagnosis of asbestosis (Group I). These nine were compared by analytic electron microscopy with nine persons with idiopathic pulmonary fibrosis (Group II), and with nine persons with all the criteria of asbestosis (Group III). The three groups did not differ significantly with respect to lung burden of chrysotile or tremolite and actinolite, but Group III had a lung burden of amosite and crocidolite that was three orders of magnitude greater than in Groups I and II, with no overlap. We conclude that (1) the American Thoracic Society criterion of "a reliable history of exposure" is sometimes difficult to define; (2) asbestos bodies are seen in tissue sections only when exposure has been reasonably high, and given the proper clinical setting, the presence of diffuse fibrosis and asbestos bodies in tissue sections are sensitive and specific criteria for a diagnosis of asbestosis; and (3) the prevalence here of 5.1% nonasbestos-induced interstitial lung disease among asbestos-exposed persons is artefactually high because of atypical case selection. However, because asbestosis is a disappearing disease, such cases will become more frequent. The identification of these other diseases is important because therapy and prognosis may differ from that of asbestosis.

Entities:  

Mesh:

Year:  1991        PMID: 1892312     DOI: 10.1164/ajrccm/144.3_Pt_1.689

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.

Authors:  I D Johnston; R J Prescott; J C Chalmers; R M Rudd
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

2.  Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges.

Authors:  Paolo Spagnolo; Roberto Tonelli; Elisabetta Cocconcelli; Alessandro Stefani; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2012-11-12

3.  A retired shipyard worker with rapidly progressive pulmonary interstitial fibrosis.

Authors:  E V Moy; H Hu; D C Christiani
Journal:  Environ Health Perspect       Date:  1999-04       Impact factor: 9.031

Review 4.  Biopersistence of respirable synthetic fibers and minerals: point of view of the chest physician.

Authors:  P De Vuyst
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

5.  An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease.

Authors:  Junichi Tanaka; Hiroshi Moriyama; Masaki Terada; Toshinori Takada; Eiichi Suzuki; Ichiei Narita; Yoshinori Kawabata; Tetsuo Yamaguchi; Akira Hebisawa; Fumikazu Sakai; Hiroaki Arakawa
Journal:  BMJ Open       Date:  2014-03-27       Impact factor: 2.692

6.  Reply to Sanyal et al.: Overlooked Role of Histopathology in Evaluations for Occupational/Environmental Exposures.

Authors:  Daniel A Culver; Sanjay Mukhopadhyay; Jurgen Behr; Hyun Kim
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.